Literature DB >> 33622288

Facial tremor in patients with Parkinson's disease: prevalence, determinants and impacts on disease progression.

Ruwei Ou1, Qianqian Wei1, Yanbing Hou1, Lingyu Zhang1, Kuncheng Liu1, Junyu Lin1, Zheng Jiang1, Bi Zhao1, Bei Cao1, Huifang Shang2.   

Abstract

BACKGROUND: Facial (lip and jaw) tremor (FT) is associated with Parkinson's disease (PD) but few studies have been conducted to explore its clinical profile. We performed this study to investigate the prevalence and clinical correlates of FT in PD, and further to evaluate its effect on disease progression.
METHODS: A retrospective, cross-sectional (n = 2224) and longitudinal (n = 674) study was conducted. The presence of FT was based on a ≥ 1 score in the United PD Rating Scale (UPDRS) item 20A. Group comparisons were conducted, followed by a forward binary logistic regression analysis. Inverse probability of treatment weighting (IPTW) based on the propensity score and weighted or unweighted Cox regression models were used to explore the impact of FT on five clinical milestones including death, UPDRS III 11-point increase, Hoehn and Yahr (H&Y) stage reaching 3, dyskinesia development, and Montreal Cognitive Assessment 3-point decrease.
RESULTS: FT was presented in 403 patients (18.1%), which showed increasing trends with disease duration and H&Y score. Age (P < 0.001), female (P < 0.001), disease duration (P = 0.001), speech (P = 0.011), rigidity (P = 0.026), rest tremor on limbs (P < 0.001), kinetic tremor on hands (P < 0.001), and axial symptoms (P = 0.013) were independent factors associated with FT. Both unweighted and weighted Cox regression models indicated that baseline FT and FT as the initial symptom were not associated with the five outcomes.
CONCLUSIONS: Our study suggested that FT was not uncommon and provided a deeper insight into the characteristics of FT in PD. The predict value of FT on long-term progronis of PD may need future longer follwe-up study.

Entities:  

Keywords:  Facial tremor; Parkinson’s disease; Prevalence; Prognosis; Rest tremor

Mesh:

Year:  2021        PMID: 33622288      PMCID: PMC7901083          DOI: 10.1186/s12883-021-02105-y

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  32 in total

1.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

2.  Rest tremor in Parkinson's disease: Body distribution and time of appearance.

Authors:  Angelo Fabio Gigante; Roberta Pellicciari; Giovanni Iliceto; Daniele Liuzzi; Paola Vincenza Mancino; Giacomo Emanuele Custodero; Marco Guido; Paolo Livrea; Giovanni Defazio
Journal:  J Neurol Sci       Date:  2016-12-28       Impact factor: 3.181

3.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

4.  Validation of the Chinese non-motor symptoms scale for Parkinson's disease: results from a Chinese pilot study.

Authors:  Gang Wang; Zhen Hong; Qi Cheng; Qin Xiao; Ying Wang; Jing Zhang; Jian-fang Ma; Xi-jin Wang; Hai-yan Zhou; Sheng-di Chen
Journal:  Clin Neurol Neurosurg       Date:  2009-03-17       Impact factor: 1.876

5.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

Review 6.  Paradoxical aspects of parkinsonian tremor.

Authors:  Paul S Fishman
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

7.  Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.

Authors:  Jennifer Wojtala; Ines Ann Heber; Petra Neuser; Julia Heller; Elke Kalbe; Sarah P Rehberg; Alexander Storch; Katharina Linse; Christine Schneider; Susanne Gräber; Daniela Berg; Judith Dams; Monika Balzer-Geldsetzer; Rüdiger Hilker-Roggendorf; Carola Oberschmidt; Simon Baudrexel; Karsten Witt; Nele Schmidt; Günther Deuschl; Brit Mollenhauer; Claudia Trenkwalder; Inga Liepelt-Scarfone; Annika Spottke; Sandra Roeske; Ullrich Wüllner; Hans-Ulrich Wittchen; Oliver Riedel; Richard Dodel; Jörg B Schulz; Kathrin Reetz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-10-08       Impact factor: 10.154

8.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

Authors:  Christopher G Goetz; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Glenn T Stebbins; Matthew B Stern; Barbara C Tilley; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J Van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2007-01       Impact factor: 10.338

9.  α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.

Authors:  Beate Ritz; Shannon L Rhodes; Yvette Bordelon; Jeff Bronstein
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

Review 10.  Sex differences in Parkinson's disease.

Authors:  Glenda E Gillies; Ilse S Pienaar; Shiv Vohra; Zahi Qamhawi
Journal:  Front Neuroendocrinol       Date:  2014-03-04       Impact factor: 8.606

View more
  1 in total

1.  Differentiating Progressive Supranuclear Palsy and Parkinson's Disease With Head-Mounted Displays.

Authors:  Arvid Herwig; Almedin Agic; Hans-Jürgen Huppertz; Randolf Klingebiel; Frédéric Zuhorn; Werner X Schneider; Wolf-Rüdiger Schäbitz; Andreas Rogalewski
Journal:  Front Neurol       Date:  2021-12-23       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.